Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
Recruiting now
Conditions studied: Bladder Cancer
In brief
Muscle invasive bladder cancer (MIBC) has a poor prognosis even after radical cystectomy. Postoperative survival stratification based on radiomics and deep learning may be useful for treatment decisions to improve prognosis. This study was aimed to develop and validate a deep learning radiomics model based on preoperative enhanced CT to predict postoperative survival in MIBC.
Key facts
- Study ID
- NCT06092450
- Run by
- First Affiliated Hospital of Chongqing Medical University
- People needed
- 500
- Starts
- 2023-08-01
- Expected to finish
- 2025-06-01
- Last updated by the study team
- 2025-05-31
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients with pathologically confirmed MIBC after radical cystectomy;
- contrast-CT scan less than two weeks before surgery;
- complete CT image data and clinical data.
You may not qualify if…
- patients who received neoadjuvant therapy;
- non-urothelial carcinoma;
- poor quality of CT images;
- incomplete clinical and follow-up data.
Where it is running
- Department of Urology, The First Affiliated Hospital of Chongqing Medical University — Chongqing, Chongqing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.